Cargando…
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
The multidrug‐resistance (MDR) phenotype is typically observed in patients with refractory epilepsy (RE) whose seizures are not controlled despite receiving several combinations of more than two antiseizure medications (ASMs) directed against different ion channels or neurotransmitter receptors. Sin...
Autores principales: | Czornyj, Liliana, Auzmendi, Jerónimo, Lazarowski, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340303/ https://www.ncbi.nlm.nih.gov/pubmed/34542938 http://dx.doi.org/10.1002/epi4.12537 |
Ejemplares similares
-
Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020) -
A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022) -
Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021) -
Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020) -
Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)